ClinicalTrials.gg
RecruitingNCT06681649IMPACT-ICUUpdated Dec 4, 2024

Pilot Feasibility Study of a Pragmatic Mixed-Methods Randomized Controlled Trial on a Follow-Up Bundle of Care for ICU Survivors and Caregivers

An interventional study of Intervention in Critical Illness and Delirium in the Intensive Care Unit, sponsored by Queen's University. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-04.

Primary conditionDeliriumRegistry: Critical IllnessReclassifiedWhy we changed it
Registry
Critical Illness — the first condition term the registry derived for this study.
ClinicalTrials.gg
Delirium
Why
  1. Critical Illness is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Delirium.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Queen's University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Jun 2024, registered Oct 2024).
  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 80 studies in Delirium with a site in Canada — 16 open to participants now, 24 under way, 2 of them phase 3. Delirium · Canada.

Planned enrollment
42nd of 53
40 · median 88
Started
2024
with 3 others
No phase
33 of 80
6 open now
Primary completion
2025-06
later than 6 of 23 live
Registered
74th of 80
by date
Lead sponsor
3 of 80
Queen's University

Among the 80 studies in Delirium with a site in Canada, this one is the 42nd largest by planned enrollment of the 53 interventional ones that give a count, is one of 4 that started in 2024, is one of 33 with no phase, reaches primary completion later than 6 of the 23 other live ones, and was the 74th registered.

Delirium

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

Browse Delirium studies →

Open to participants now

16 of the 80 studies in Delirium with a site in Canada are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 80 studies in Delirium with a site in Canada, or all of them as a file.
02

Study summary

\~80% of ICU survivors experience profound long-term cognitive, physical, and psychiatric impairments known as post-intensive care syndrome (PICS). Caregivers additionally experience similar detrimental psychosocial effects following discharge. Despite this knowledge, follow-up care is almost non-existent. ICU follow-up clinics may mitigate these long-term impacts, but lack evaluation of their effectiveness. This trial will evaluate the effectiveness of ICU follow-up clinics vs. standard-of-care in improving qualitative/clinical outcomes of ICU survivors and caregivers, with those receiving follow-up care hypothesized to have improved outcomes.

Read the detailed description

\~80% of ICU survivors experience profound long-term cognitive, physical, and psychiatric impairments known as post-intensive care syndrome (PICS), with patients experiencing prolonged delirium or mechanical ventilation having a heightened risk. Caregivers additionally experience similar detrimental psychosocial effects following discharge. Despite this knowledge, follow-up care is almost non-existent. ICU follow-up clinics may mitigate these long-term impacts, but lack evaluation of their effectiveness. This pragmatic, mixed-methods, open-label randomized (1:1) controlled trial will evaluate the effectiveness of ICU follow-up clinics vs. standard-of-care in improving qualitative/clinical outcomes of ICU survivors and caregivers, with those receiving follow-up care hypothesized to have improved outcomes.

The intervention group will receive: 1) specialized follow-up care at 1- and 3-months following discharge, 2) information packages on expectations following discharge, and 3) diaries for the healthcare team, family, and patient to journal their experiences throughout recovery. The control group will receive generalized standard of care through their primary care provider. Focus groups will be used for qualitative assessment to elucidate what patients find most important for their recovery, using a patient-centred approach. Clinical assessments will evaluate neurocognitive function, quality of life, anxiety, depression, post-traumatic stress disorder, and resiliency among both ICU survivors and caregivers; chronic pain, fatigue, activities of daily living, lower extremity strength, polypharmacy, and hospital readmissions among ICU survivors; and caregiver burden and sleep quality among caregivers.

ICU survivorship extends beyond surviving the ICU. This program of research will unravel the aspects of follow-up care needed to mitigate the long-term impacts of PICS and improve patient and caregiver outcomes. This study is a first-step toward achieving this goal, by understanding barriers to successful recruitment, enrolment, data collection, and follow-up in this vulnerable cohort of ICU survivors and caregivers.

03

Conditions studied

  • Critical Illness
  • Delirium in the Intensive Care Unit

Browse trials for

Keywords

  • critical illness
  • delirium
  • post-intensive care syndrome
04

In context

Delirium Reclassified

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

This study's planned enrollment of 40 is below the median of 111 across 551 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Queen's University is the lead sponsor of 207 studies on the registry; 15 are open to participants now.

Compared within Delirium, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Critical Illness. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion criteria - ICU survivors

  1. Adult patients (age greater than or equal to 18 years)
  2. greater than or equal to 6 months as determined by the attending physician
  3. High risk for long-term functional sequelae following ICU discharge, defined as ICU stay greater than or equal to 4 days, or involving at least one of:

    • mechanical ventilation (any, i.e., invasive or non-invasive)
    • tracheostomy
    • delirium (defined as Confusion Assessment Method (CAM) positive or documented history of delirium in the patient's medical record by the clinical care team at some point during their ICU admission)
    • lack of access to a primary care physician for clinical follow-up
    • access to email or mail to complete follow-up questionnaires
    • presence of an informal caregiver

Inclusion criteria - Caregivers

  1. Informal caregiver (e.g., spouse, offspring) for ICU survivor as defined above
  2. Adult (age greater than or equal to 18 years)

Exclusion criteria - ICU survivors and caregivers

  • Neurological or communication difficulties which would preclude completion of follow-up assessments or participation in focus groups
  • Inability to speak or read English (required for completion of standardized questionnaires, clinical assessments, and for participation in focus groups)
  • Failure to provide consent/failure to have consent provided by a substitute decision maker
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

06

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Intervention

    The intervention group will receive follow-up care through the specialized post-ICU follow-up clinic at KHSC at approximately 1- and 3-months following ICU discharge. Caregivers will also be invited to participate in the follow-up clinic along with the ICU survivor participant. In addition to receiving specialized follow-up clinical care, ICU survivor participants and their caregivers will also receive the following additional items as part of a bundled care intervention program (see Appendix): * Informational pamphlet on critical illness and expectations following ICU discharge * Flyer on critical illness and expectations following ICU discharge (brief version, which may be placed on the participant's refrigerator or other location at home as a consistent reminder) * Diaries in which the healthcare team, family members, and the patient themselves are able to journal their experiences, updates, progress, and barriers in the ICU and following discharge

    Behavioral: Intervention

  • No intervention
    Control

    The control group will receive generalized standard of care follow-up through their primary care provider. This follow-up is highly variable depending on the patient and their primary care provider.

Interventions

  • BehavioralIntervention

    The intervention group will receive follow-up care through the specialized post-ICU follow-up clinic at KHSC at approximately 1- and 3-months following ICU discharge. Caregivers will also be invited to participate in the follow-up clinic along with the ICU survivor participant. In addition to receiving specialized follow-up clinical care, ICU survivor participants and their caregivers will also receive the following additional items as part of a bundled care intervention program (see Appendix): * Informational pamphlet on critical illness and expectations following ICU discharge * Flyer on critical illness and expectations following ICU discharge (brief version, which may be placed on the participant's refrigerator or other location at home as a consistent reminder) * Diaries in which the healthcare team, family members, and the patient themselves are able to journal their experiences, updates, progress, and barriers in the ICU and following discharge

07

What researchers measure

Primary outcomes

  1. Feasibility - Consent Rate

    To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measure: Consent rate, measured as the proportion of eligible population who consent to participate

    Time frame: 6 months

  2. Feasibility - Enrolment Rate

    To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measures: Enrolment rate, measured as the proportion of consented participants who are randomized

    Time frame: 6 months

  3. Feasibility - Follow-Up Rate

    To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measures: Follow-up rate, measured as the proportion of enrolled participants who complete follow-up visits at 1-, 3-, and 6-months

    Time frame: 6 months

  4. Feasibility - Data Capture Rate

    To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measures: Data capture rate, measured as the percentage of data elements acquired at each study time point

    Time frame: 6 months

  5. Feasibility - Rate of adverse events

    To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measures: Rate of adverse events, assessed using the number of hospital and ICU readmissions, as well as the number of visits to the emergency department at 6 months.

    Time frame: 6 months

Secondary outcomes

  1. Qualitative impact of intervention

    To determine the qualitative impact of a post-ICU follow-up care intervention on patients and caregivers, as assessed via qualitative analysis of focus group discussions.

    Time frame: 6 months

  2. Process evaluation

    To perform a process evaluation of the multimodal ICU follow-up bundle of care intervention to understand the implementation, acceptability, content, barriers, and facilitators to use of diaries, informational materials, and the follow-up clinic.

    Time frame: 6 months

Other outcomes

  1. Neurocognition

    Neurocognitive outcomes, as measured using the MoCA

    Time frame: 6 months

  2. Weight and BMI

    To determine the effect of a post-ICU follow-up clinic intervention on changes in weight and body-mass index (BMI) following ICU discharge

    Time frame: 6 months

  3. Clinical Outcome

    Frailty, as measured using the CFS

    Time frame: 6 months

  4. Quality of Life

    Quality of life outcomes, as measured using the SF-36

    Time frame: 6 months

  5. Anxiety and mood

    Anxiety and depression, as measured using the HADS

    Time frame: 6 months

  6. Post-traumatic stress

    PTSD, as measured using the PTSS-14

    Time frame: 6 months

  7. Chronic pain

    Chronic pain, as measured using the Chronic Pain Grade Scale (CPGS)

    Time frame: 6 months

  8. Fatigue

    Chronic fatigue, as measured using the Fatigue Severity Scale (FSS)

    Time frame: 6 months

  9. Activities of daily living

    Activities of daily living (ADLs), as measured using the Katz Index of ADLs

    Time frame: 6 months

  10. Instrumental activities of daily living

    Instrumental ADLs, as measured using the Lawton IADL score

    Time frame: 6 months

  11. Physical function

    Lower extremity strength, as measured using the 30-second Sit-to-Stand Test

    Time frame: 6 months

  12. Resiliency

    Dyadic resiliency among ICU survivors and caregivers, as measured using the dyadic Connor-Davidson 10-item Resiliency Scale (CD-RISC-10)

    Time frame: 6 months

  13. Return to work

    To determine the effect of a post-ICU follow-up clinic intervention on return to work by ICU survivors

    Time frame: 6 months

  14. Employment status of caregivers

    Employment status relative to previous among caregivers

    Time frame: 6 months

08

Study locations

1 of 1 sites recruiting
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Jun 2025, 12 months after the start.

Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 12 months is below that.

Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2024
First posted
Nov 8, 2024
StartActual
Jun 1, 2024
Primary completionEst.
Jun 1, 2025
CompletionEst.
Jun 1, 2025
Last update
Dec 4, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06681649
Lead sponsor
Queen's University
Responsible party
Dr. Gordon Boyd (Associate Professor, Queen's University) — Principal investigator
First posted
Nov 8, 2024
Start date
Jun 1, 2024
Primary completion
Jun 1, 2025 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
Dec 4, 2024

Study contacts

J G Boyd, MD PhD
Contact
gordon.boyd@kingstonhsc.ca
6135496666 x6228 ext. 6228
Natasha A Jawa, MSc
Contact
tasha.jawa@queensu.ca

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion